Mohammed Shahait
Overview
Explore the profile of Mohammed Shahait including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
283
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Shahait M, Usamentiaga R, Tong Y, Sandberg A, Lee D, Udupa J, et al.
World J Urol
. 2024 Jun;
42(1):375.
PMID: 38872048
Background: The International Prostate Symptom Score (IPSS) is a patient-reported measurement to assess the lower urinary tract symptoms of bladder outlet obstruction. Bladder outlet obstruction induces molecular and morphological alterations...
12.
Alhajahjeh A, Al-Faouri R, Bahmad H, Bader T, Dobbs R, Abdulelah A, et al.
Cancers (Basel)
. 2024 Apr;
16(8).
PMID: 38672620
Glucagon-like peptide-1 (GLP-1), an incretin hormone renowned for its role in post-meal blood sugar regulation and glucose-dependent insulin secretion, has gained attention as a novel treatment for diabetes through GLP-1...
13.
Shahait M, Nguyen T, Xuong Duong N, Mucksavage P, Somani B
Cent European J Urol
. 2024 Apr;
77(1):140-151.
PMID: 38645811
Introduction: Several studies have compared the safety and effectiveness of general and regional anaesthesia in percutaneous nephrolithotomy (PCNL). This study aimed to compare the perioperative and postoperative outcomes of general...
14.
Shahait M, Hakansson A, Daniel R, Hosny K, Davicioni E, Liu S, et al.
Prostate
. 2024 Mar;
84(8):709-716.
PMID: 38544351
Objective: To morphologically describe tertiary lymphoid structures (TLS) in prostatectomy specimens and correlate them with clinical and transcriptomic features. Methodology: A total of 72 consecutive cases of entirely submitted radical...
15.
Alhajahjeh A, Abdulelah A, Hmeidan M, Kakish D, Sukerji R, Qtaishat L, et al.
World J Urol
. 2024 Mar;
42(1):174.
PMID: 38506931
Background: Over the past 2 decades, there has been a growing interest in the significance of gender roles in healthcare and several efforts and initiatives have focused on increasing female...
16.
Halaseh S, Al-Karadsheh A, Mukherji D, Alhjahaja A, Farkouh A, Al-Ibraheem A, et al.
Ecancermedicalscience
. 2024 Feb;
17:1629.
PMID: 38414940
Background: Prostate cancer is the second most common form of cancer and a leading cause of cancer-related death in men. In an era of evidence-based medicine, clinical trials play a...
17.
Baqain L, Mukherji D, Al-Shamsi H, Abu-Gheida I, Al-Ibraheem A, Rabii K, et al.
Ecancermedicalscience
. 2024 Feb;
17:1646.
PMID: 38414928
[This corrects the article DOI: 10.3332/ecancer.2023.1573.].
18.
Al-Ibraheem A, Istatieh F, Abdlkadir A, Shahait M, Khreish F
Clin Nucl Med
. 2024 Jan;
49(3):262-264.
PMID: 38271240
Cerebral and muscular metastases from prostatic adenocarcinoma occur rarely. Patients who develop such metastatic pattern exhibit noticeable symptoms. Herein, we present a 68-year-old man diagnosed with metastatic castrate-resistant prostate cancer....
19.
Al-Rashdan R, Al-Abdallat H, Sathekge M, Mirzaei S, Shahait M, Al-Khawaldeh K, et al.
Nuklearmedizin
. 2024 Jan;
63(3):188-198.
PMID: 38262473
Aim: The integration of innovative radio-pharmaceutical agents targeting prostate-specific membrane antigen (PSMA) within nuclear medicine has transformed prostate cancer detection and management. This study aims to investigate the present landscape...
20.
Alhajahjeh A, Hmeidan M, Elatrsh M, Al-Abbadi F, Kakish D, Sukerji R, et al.
JCO Glob Oncol
. 2024 Jan;
10:e2300349.
PMID: 38207249
Purpose: Clinical trials are valuable evidence for managing urologic malignancies. Early termination of clinical trials is associated with a waste of resources and may substantially affect patient care. We sought...